Lupin Receives Tentative USFDA Approval for Generic Pitolisant Tablets
New Delhi, March 25 – Lupin Ltd announced on Wednesday that it has received tentative approval from the US health regulator for its generic version of Pitolisant tablets, indicated for the treatment of excessive daytime...
abbreviated new drug application
drug development
drug manufacturing
excessive daytime sleepiness
genericpharmaceuticals
healthcare
india
lupin ltd
nagpur
pharmaceutical approval
pharmaceutical industry
pitolisant
regulatory filings
tablet
us food and drug administration (usfda)
Penicillin G Expansion Gains Momentum in Kakinada SEZ
Aurobindo Pharma is stepping up its Penicillin G production, with plans to manufacture more than 10,000 metric tonnes annually over the next 12 months, according to Chief Financial Officer S Subramanian.The Hyderabad-based pharmaceutical...